NiKang partners with Roche on liver cancer drug study
December 11, 2023
NiKang Therapeutics has signed a new collaboration agreement with the Swiss pharmaceutical giant Roche to study a deadly liver cancer.
chat_bubble0 Comment
visibility702 Views
Premier Digital Partners
© 2024 Delaware Business Times
